Noven Pharmaceuticals Inc. (Nasdaq: NOVN) received a $428 million cash offer from Japan-based Hisamitsu Pharmaceutical. The stock price surged $2.97 to $16.45.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.